(29)Commission Implementing Regulation (EU) 2024/324note extended the approval period of the active substance flutolanil until 15 June 2025, and the approval period of the active substance mecoprop-P until 15 May 2025.
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.